Trevi Therapeutics, Inc. TRVI Stock options excluded as their inclusion would be anti-dilutive (in shares)
Stock options excluded as their inclusion would be anti-dilutive (in shares) at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s stock options excluded as their inclusion would be anti-dilutive (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s stock options excluded as their inclusion would be anti-dilutive (in shares)?
- Trevi Therapeutics, Inc. (TRVI) reported stock options excluded as their inclusion would be anti-dilutive (in shares) of 13.9M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s stock options excluded as their inclusion would be anti-dilutive (in shares) changed year-over-year?
- Trevi Therapeutics, Inc.'s stock options excluded as their inclusion would be anti-dilutive (in shares) increased by 1.5% year-over-year, from 13.7M to 13.9M.
- What does stock options excluded as their inclusion would be anti-dilutive (in shares) mean?
- This metric counts the number of stock options and other equity instruments excluded from the diluted earnings per share calculation because their inclusion would be anti-dilutive. It provides transparency regarding potential future dilution that is currently excluded due to the company's net loss position. Investors use this to assess the total potential overhang of equity-based awards.